title: Reduced HLA Class II antibody response to proteasome inhibition in heart transplantation.
authors: UCLA Transplantation Services.
authors: Tam
authors: T
authors: Khuu
authors: Department of Medicine, Division of Cardiology.
authors: Martin
authors: M
authors: Cadeiras
authors: Department of Medicine, Division of Cardiology.
authors: Nicholas
authors: N
authors: Wisniewski
authors: UCLA Pathology & Laboratory Medicine Immunogenetics Center, University of California, Los Angeles, Los Angeles, California.
authors: Elaine F
authors: EF
authors: Reed
authors: Department of Medicine, Division of Cardiology.
authors: Mario C
authors: MC
authors: Deng
mesh_terms: D000328:Adult; D000906:Antibodies / Q000097:blood*; D000917:Antibody Formation / Q000187:drug effects*; D000069286:Bortezomib / Q000494:pharmacology; D003627:Data Interpretation, Statistical; D005260:Female; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D006680:HLA Antigens / Q000276:immunology*; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D061988:Proteasome Inhibitors / Q000494:pharmacology*; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D006680:HLA Antigens; D061988:Proteasome Inhibitors; D000069286:Bortezomib